United States Hepatitis A Vaccine Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Hepatitis A Vaccine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Hepatitis A Vaccine Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Hepatitis A Vaccine Overall Market Size
2.1 United States Hepatitis A Vaccine Market Size: 2021 VS 2027
2.2 United States Hepatitis A Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Hepatitis A Vaccine Sales: 2016-2027
3 Company Landscape
3.1 Top Hepatitis A Vaccine Players in United States Market
3.2 Top United States Hepatitis A Vaccine Companies Ranked by Revenue
3.3 United States Hepatitis A Vaccine Revenue by Companies
3.4 United States Hepatitis A Vaccine Sales by Companies
3.5 United States Hepatitis A Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Hepatitis A Vaccine Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Hepatitis A Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hepatitis A Vaccine Players in United States Market
3.8.1 List of Tier 1 Hepatitis A Vaccine Companies in United States
3.8.2 List of Tier 2 and Tier 3 Hepatitis A Vaccine Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Hepatitis A Vaccine Market Size Markets, 2021 & 2027
4.1.2 Inactivated Vaccine
4.1.3 Live Attenuated Vaccine
4.2 By Type - United States Hepatitis A Vaccine Revenue & Forecasts
4.2.1 By Type - United States Hepatitis A Vaccine Revenue, 2016-2021
4.2.2 By Type - United States Hepatitis A Vaccine Revenue, 2022-2027
4.2.3 By Type - United States Hepatitis A Vaccine Revenue Market Share, 2016-2027
4.3 By Type - United States Hepatitis A Vaccine Sales & Forecasts
4.3.1 By Type - United States Hepatitis A Vaccine Sales, 2016-2021
4.3.2 By Type - United States Hepatitis A Vaccine Sales, 2022-2027
4.3.3 By Type - United States Hepatitis A Vaccine Sales Market Share, 2016-2027
4.4 By Type - United States Hepatitis A Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Hepatitis A Vaccine Market Size, 2021 & 2027
5.1.2 Government Institution
5.1.3 Private Sector
5.1.4 Other
5.2 By Application - United States Hepatitis A Vaccine Revenue & Forecasts
5.2.1 By Application - United States Hepatitis A Vaccine Revenue, 2016-2021
5.2.2 By Application - United States Hepatitis A Vaccine Revenue, 2022-2027
5.2.3 By Application - United States Hepatitis A Vaccine Revenue Market Share, 2016-2027
5.3 By Application - United States Hepatitis A Vaccine Sales & Forecasts
5.3.1 By Application - United States Hepatitis A Vaccine Sales, 2016-2021
5.3.2 By Application - United States Hepatitis A Vaccine Sales, 2022-2027
5.3.3 By Application - United States Hepatitis A Vaccine Sales Market Share, 2016-2027
5.4 By Application - United States Hepatitis A Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Overview
6.1.3 GSK Hepatitis A Vaccine Sales and Revenue in United States Market (2016-2021)
6.1.4 GSK Hepatitis A Vaccine Product Description
6.1.5 GSK Recent Developments
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Overview
6.2.3 Merck Hepatitis A Vaccine Sales and Revenue in United States Market (2016-2021)
6.2.4 Merck Hepatitis A Vaccine Product Description
6.2.5 Merck Recent Developments
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Overview
6.3.3 Sanofi Hepatitis A Vaccine Sales and Revenue in United States Market (2016-2021)
6.3.4 Sanofi Hepatitis A Vaccine Product Description
6.3.5 Sanofi Recent Developments
6.4 Sinovac
6.4.1 Sinovac Corporation Information
6.4.2 Sinovac Overview
6.4.3 Sinovac Hepatitis A Vaccine Sales and Revenue in United States Market (2016-2021)
6.4.4 Sinovac Hepatitis A Vaccine Product Description
6.4.5 Sinovac Recent Developments
6.5 Zhejiang Pukang
6.5.1 Zhejiang Pukang Corporation Information
6.5.2 Zhejiang Pukang Overview
6.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales and Revenue in United States Market (2016-2021)
6.5.4 Zhejiang Pukang Hepatitis A Vaccine Product Description
6.5.5 Zhejiang Pukang Recent Developments
6.6 Changchun Institute of Biological
6.6.1 Changchun Institute of Biological Corporation Information
6.6.2 Changchun Institute of Biological Overview
6.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales and Revenue in United States Market (2016-2021)
6.6.4 Changchun Institute of Biological Hepatitis A Vaccine Product Description
6.6.5 Changchun Institute of Biological Recent Developments
6.7 KM Biologics
6.7.1 KM Biologics Corporation Information
6.7.2 KM Biologics Overview
6.7.3 KM Biologics Hepatitis A Vaccine Sales and Revenue in United States Market (2016-2021)
6.7.4 KM Biologics Hepatitis A Vaccine Product Description
6.7.5 KM Biologics Recent Developments
6.8 IMBCA
6.8.1 IMBCA Corporation Information
6.8.2 IMBCA Overview
6.8.3 IMBCA Hepatitis A Vaccine Sales and Revenue in United States Market (2016-2021)
6.8.4 IMBCA Hepatitis A Vaccine Product Description
6.8.5 IMBCA Recent Developments
6.9 ChangSheng
6.9.1 ChangSheng Corporation Information
6.9.2 ChangSheng Overview
6.9.3 ChangSheng Hepatitis A Vaccine Sales and Revenue in United States Market (2016-2021)
6.9.4 ChangSheng Hepatitis A Vaccine Product Description
6.9.5 ChangSheng Recent Developments
6.10 Convac
6.10.1 Convac Corporation Information
6.10.2 Convac Overview
6.10.3 Convac Hepatitis A Vaccine Sales and Revenue in United States Market (2016-2021)
6.10.4 Convac Hepatitis A Vaccine Product Description
6.10.5 Convac Recent Developments
7 United States Hepatitis A Vaccine Production Capacity, Analysis
7.1 United States Hepatitis A Vaccine Production Capacity, 2016-2027
7.2 Hepatitis A Vaccine Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Hepatitis A Vaccine Supply Chain Analysis
9.1 Hepatitis A Vaccine Industry Value Chain
9.2 Hepatitis A Vaccine Upstream Market
9.3 Hepatitis A Vaccine Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Hepatitis A Vaccine Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Hepatitis A Vaccine in United States Market
Table 2. Top Hepatitis A Vaccine Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Hepatitis A Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Hepatitis A Vaccine Revenue Share by Companies, 2016-2021
Table 5. United States Hepatitis A Vaccine Sales by Companies, (K Unit), 2016-2021
Table 6. United States Hepatitis A Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Hepatitis A Vaccine Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Hepatitis A Vaccine Product Type
Table 9. List of Tier 1 Hepatitis A Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Hepatitis A Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Inactivated Vaccine
Table 12. Major Manufacturers of Live Attenuated Vaccine
Table 13. By Type - United States Hepatitis A Vaccine Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Hepatitis A Vaccine Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Hepatitis A Vaccine Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Hepatitis A Vaccine Sales (K Unit), 2016-2021
Table 17. By Type - United States Hepatitis A Vaccine Sales (K Unit), 2022-2027
Table 18. By Application - United States Hepatitis A Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Hepatitis A Vaccine Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Hepatitis A Vaccine Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Hepatitis A Vaccine Sales (K Unit), 2016-2021
Table 22. By Application - United States Hepatitis A Vaccine Sales (K Unit), 2022-2027
Table 23. GSK Corporation Information
Table 24. GSK Description and Major Businesses
Table 25. GSK Hepatitis A Vaccine Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. GSK Hepatitis A Vaccine Product
Table 27. GSK Recent Developments
Table 28. Merck Corporation Information
Table 29. Merck Description and Major Businesses
Table 30. Merck Hepatitis A Vaccine Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. Merck Hepatitis A Vaccine Product
Table 32. Merck Recent Developments
Table 33. Sanofi Corporation Information
Table 34. Sanofi Description and Major Businesses
Table 35. Sanofi Hepatitis A Vaccine Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Sanofi Hepatitis A Vaccine Product
Table 37. Sanofi Recent Developments
Table 38. Sinovac Corporation Information
Table 39. Sinovac Description and Major Businesses
Table 40. Sinovac Hepatitis A Vaccine Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Sinovac Hepatitis A Vaccine Product
Table 42. Sinovac Recent Developments
Table 43. Zhejiang Pukang Corporation Information
Table 44. Zhejiang Pukang Description and Major Businesses
Table 45. Zhejiang Pukang Hepatitis A Vaccine Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Zhejiang Pukang Hepatitis A Vaccine Product
Table 47. Zhejiang Pukang Recent Developments
Table 48. Changchun Institute of Biological Corporation Information
Table 49. Changchun Institute of Biological Description and Major Businesses
Table 50. Changchun Institute of Biological Hepatitis A Vaccine Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. Changchun Institute of Biological Hepatitis A Vaccine Product
Table 52. Changchun Institute of Biological Recent Developments
Table 53. KM Biologics Corporation Information
Table 54. KM Biologics Description and Major Businesses
Table 55. KM Biologics Hepatitis A Vaccine Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. KM Biologics Hepatitis A Vaccine Product
Table 57. KM Biologics Recent Developments
Table 58. IMBCA Corporation Information
Table 59. IMBCA Description and Major Businesses
Table 60. IMBCA Hepatitis A Vaccine Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 61. IMBCA Hepatitis A Vaccine Product
Table 62. IMBCA Recent Developments
Table 63. ChangSheng Corporation Information
Table 64. ChangSheng Description and Major Businesses
Table 65. ChangSheng Hepatitis A Vaccine Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 66. ChangSheng Hepatitis A Vaccine Product
Table 67. ChangSheng Recent Developments
Table 68. Convac Corporation Information
Table 69. Convac Description and Major Businesses
Table 70. Convac Hepatitis A Vaccine Sales (K Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 71. Convac Hepatitis A Vaccine Product
Table 72. Convac Recent Developments
Table 73. Hepatitis A Vaccine Production Capacity (K Unit) of Key Manufacturers in United States Market, 2019-2021 (K Unit)
Table 74. United States Hepatitis A Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
Table 75. Hepatitis A Vaccine Market Opportunities & Trends in United States Market
Table 76. Hepatitis A Vaccine Market Drivers in United States Market
Table 77. Hepatitis A Vaccine Market Restraints in United States Market
Table 78. Hepatitis A Vaccine Raw Materials
Table 79. Hepatitis A Vaccine Raw Materials Suppliers in United States Market
Table 80. Typical Hepatitis A Vaccine Downstream
Table 81. Hepatitis A Vaccine Downstream Clients in United States Market
Table 82. Hepatitis A Vaccine Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Hepatitis A Vaccine Product Picture
Figure 2. Hepatitis A Vaccine Segment by Type
Figure 3. Hepatitis A Vaccine Segment by Application
Figure 4. United States Hepatitis A Vaccine Market Overview: 2020
Figure 5. United States Hepatitis A Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Hepatitis A Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. Hepatitis A Vaccine Sales in United States Market: 2016-2027 (K Unit)
Figure 8. The Top 3 and 5 Players Market Share by Hepatitis A Vaccine Revenue in 2020
Figure 9. Inactivated Vaccine Product Picture
Figure 10. Live Attenuated Vaccine Product Picture
Figure 11. By Type - United States Hepatitis A Vaccine Sales Market Share, 2016-2027
Figure 12. By Type - United States Hepatitis A Vaccine Revenue Market Share, 2016-2027
Figure 13. By Type - United States Hepatitis A Vaccine Price (USD/Unit), 2016-2027
Figure 14. Government Institution
Figure 15. Private Sector
Figure 16. Other
Figure 17. By Application - United States Hepatitis A Vaccine Sales Market Share, 2016-2027
Figure 18. By Application - United States Hepatitis A Vaccine Revenue Market Share, 2016-2027
Figure 19. By Application - United States Hepatitis A Vaccine Price (USD/Unit), 2016-2027
Figure 20. GSK Hepatitis A Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Merck Hepatitis A Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Sanofi Hepatitis A Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Sinovac Hepatitis A Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Zhejiang Pukang Hepatitis A Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Changchun Institute of Biological Hepatitis A Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. KM Biologics Hepatitis A Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. IMBCA Hepatitis A Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. ChangSheng Hepatitis A Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Convac Hepatitis A Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. United States Hepatitis A Vaccine Production Capacity (K Unit), 2016-2027
Figure 31. Hepatitis A Vaccine Industry Value Chain
Figure 32. Marketing Channels